395 / 1778
Comparison 1
NACT followed by RT Vs RT
• 18 trials
• N = 2074
• 92% of patients from all eligible trials
• Survival data available from all trials
• Median FU – 5.7 years
• 70% pts had stage II or III disease
• Lymph node status unknown in 60%